gbr 13069 and vanoxerine
gbr 13069 has been researched along with vanoxerine in 2 studies
Compound Research Comparison
| Studies (gbr 13069) | Trials (gbr 13069) | Recent Studies (post-2010) (gbr 13069) | Studies (vanoxerine) | Trials (vanoxerine) | Recent Studies (post-2010) (vanoxerine) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 556 | 5 | 93 |
| 6 | 0 | 0 | 28 | 0 | 20 |
Protein Interaction Comparison
| Protein | Taxonomy | gbr 13069 (IC50) | vanoxerine (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.46 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.0103 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 3.84 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.0969 | |
| Small conductance calcium-activated potassium channel protein 2 | Rattus norvegicus (Norway rat) | 0.073 | |
| Small conductance calcium-activated potassium channel protein 3 | Rattus norvegicus (Norway rat) | 0.073 | |
| Small conductance calcium-activated potassium channel protein 1 | Rattus norvegicus (Norway rat) | 0.073 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.1485 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.022 | |
| Transporter | Rattus norvegicus (Norway rat) | 0.114 | |
| Mu-type opioid receptor | Homo sapiens (human) | 3.53 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 2.14 |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Heikkila, RE; Manzino, L | 1 |
| Grundt, P; Katz, JL; Kopajtic, T; Kulkarni, SS; Newman, AH | 1 |
Other Studies
2 other study(ies) available for gbr 13069 and vanoxerine
| Article | Year |
|---|---|
Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake.
Topics: Animals; Behavior, Animal; Biogenic Amines; Cerebral Cortex; Corpus Striatum; Dopamine; Female; Flunarizine; Haloperidol; Humans; Hydroxydopamines; In Vitro Techniques; Male; Mice; Motor Activity; Neurotransmitter Uptake Inhibitors; Oxidopamine; Piperazines; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1984 |
Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
Topics: Animals; Brain; Carrier Proteins; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; In Vitro Techniques; Male; Membrane Glycoproteins; Membrane Transport Proteins; Models, Molecular; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Quantitative Structure-Activity Relationship; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Serotonin Plasma Membrane Transport Proteins; Symporters; Tropanes | 2004 |